Featured Articles

Supplier of quality compounding products, supplies and equipment, Letco Medical along with ARL Bio Pharma collaborate to roll out their joint Quality Savings Program. The program…
Read More...

Clinical development Type C meeting with the US Food and Drug Administration (FDA) for its orally active anti-fibrotic lead drug candidate, PBI-4050 was declared by Prometic Life…
Read More...

In a bid to bring on board fresh participants for its weight loss surgery surgery thus making it accessible patients with  a considerably low BMI of 30-35, New Jersey Bariatric Center…
Read More...

Aradigm Corporation asserted that it received a Complete Response Letter from the US Food and Drug Administration regarding its New Drug Application (NDA) for Linhaliq for treating …
Read More...

TFS International and Arclon Biotech decided to continue their partnership with TFS advancing their Alzheimer's disease vaccine ABvac40 into phase II. AD is a progressive disease…
Read More...

Intelligent Retinal Imaging Systems (IRIS), asserted the appointment of Chris Belmont as interim CEO effective immediately.  IRIS also named Steve Martin as Chief Commercial Officer and…
Read More...

Sterling Pharma Solutions witnessed growth in the Japanese market owing to its technical capabilities and innovation strategy. Sterling's technology and innovation strategy, which has…
Read More...

Avista Pharma Solutions completed acquisition of  Solid Form Solutions located in Edinburgh, Scotland. Solid Form Solutions provider of solid state chemistry and crystallization…
Read More...

Leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, REGENXBIO, forays…
Read More...

Advanced Accelerator Applications which is a subsidiary of Novartis Groupe S.A sought U.S Food and Drug administration's assent for its New drug application (NDA) for  Lutathera …
Read More...

Novartis proclaimed a licensing agreement with Spark Therapeutics encompassing development, registration and commercialization rights to voretigene neparvovec in markets outside the US.…
Read More...

With a view to addressing a $1.8 billion market globally, and a European market estimated to exceed $500 million, TechCare Corporation a technology company with a revolutionary delivery…
Read More...

Late-stage clinical biopharmaceutical company, Liquidia Technologies focused on enhancing the performance of medicine by precisely engineering drug particles, today announced positive…
Read More...

COMPASS Trial results suggest affirmative Penumbra;s approach to effective thrombectomy approach for acute ischemic stroke as part of the ADAPT (A DirectAspiration, First Pass …
Read More...

Japan's Ministry of health, labor and Welfare extended marketing and manufacturing authorization for Regeneron's DUPIXENT for the treatment of atopic dermatitis in adults not curbed by…
Read More...

Swedish Orphan Biovitrum AB confirmed FDA's acceptance of the investigational new drug application for the drug candidate SOBI003 along with granting Fast track status to it. SOBI003 is…
Read More...

Surefire Medical affirmed the appointment of Mary T. Szela as its CEO, President and a member of the company's Board Of Directors. James Chomas PhD precedes Szela who served as…
Read More...

Puma Biotechnology asserted that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has conveyed a negative trend vote after discussions…
Read More...

Cerus Corporation asserted successful achievement of primary efficacy and safety endpoints in the Company's Phase 3 transfusion study of Chronic anaemia assessing INTERCEPT-treated Red…
Read More...

Celgene Corporation and Juno Therapeutics signed a definitive merger agreement in which Celgene has initiated acquisition of Juno Therapeutics. As per the terms of the agreement, …
Read More...